Alerts will be sent to your verified email
Verify EmailAARTIDRUGS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Aarti Drugs Limited, a key player in the pharmaceutical industry, specializes in manufacturing APIs, Pharma Intermediates, Specialty Chemicals, and Formulations including Ciprofloxacin Hydrochloride and Metronidazole.
Aarti Drugs major competitors are Morepen Laboratories, Solara Active Pharma, Bajaj Healthcare, SMS Pharmaceuticals, IOL Chem & Pharma, Themis Medicare, Hester Biosciences.
Market Cap of Aarti Drugs is ₹3,101 Crs.
While the median market cap of its peers are ₹1,886 Crs.
Aarti Drugs seems to be less financially stable compared to its competitors.
Altman Z score of Aarti Drugs is 3.96 and is ranked 6 out of its 8 competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep | |||||||||
Investor Presentation | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar May Jun Jul Aug Sep Dec | Jan Mar Jun Sep Dec | Mar Jun Sep Dec | Mar | Jun Sep Dec | |||||||||||
Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | ||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|